Connect Biopharma Holdings Ltd ADR (NASDAQ:CNTB) traded at $1.60 at close of the session on current trade day and made an upward move of 25.00% on its previous day’s price.
Looking at the stock we see that its previous close was $1.28 and the beta (5Y monthly) reads -0.39 with the day’s price range being $1.2 – $1.6. In terms of its 52-week price range, CNTB has a high of $2.84 and a low of $0.53. The company’s stock has gained about 35.59% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Connect Biopharma Holdings Ltd ADR has a market cap of $88.16 million and is expected to release its quarterly earnings report on 2023-Sep-12.
On the other hand, looking at the outlook for the CNTB stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Connect Biopharma Holdings Ltd ADR (CNTB) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 46.97% off its SMA20 and 31.46% from its 50-day simple moving average. The RSI (14) is pointing at 73.87 while the volatility over the past week is 18.77% and jumps to 10.22% over the past one month. The beta value is -0.39, while the average true range (ATR) is currently pointing at 0.13. The average price target for the stock over the next 12 months is $1.5, with the estimates having a low of $1.5 and a high of $1.5. These price ends are 6.25% and 6.25% off the current price level respectively, although investors could be excited at the prospect of a 6.25% if the CNTB share price touches on the median price of $1.5.
Coming back to Connect Biopharma Holdings Ltd ADR (NASDAQ:CNTB), we note that the average 3-month trading volume was 49.14K, while that of the preceding 10-day period stands at 55230.0. Current shares outstanding are 55.10 million.
The insiders hold 3.62% of the company’s shares while institutions hold 5.41%. The data shows that short shares as of 2024-08-15, stood at 12071.0 at a short ratio of 0.55. This represents a 4.00 short interest in shares outstanding on 2024-08-15. Shares short rose in August from the previous month at 10797.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 35.59% up in year-to-date price movement.
